Effectiveness of PENTABIOCEL in Clinical and Laboratory Recovery of Children With Celiac Disease

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

August 15, 2021

Study Completion Date

August 15, 2021

Conditions
Celiac Disease
Interventions
DIETARY_SUPPLEMENT

Pentabiocel

Pentabiocel is the trade name of the product containing the probiotic mixture of: Lactobacillus paracasei LMG P-17504, Lactobacillus plantarum CECT 4528, Bifidobacterium breve Bbr8 LMG P-17501, Bifidobacterium breve BL10 LMG P-17500 and Bifidobacterium animalis subsp lactis Bi1 LMG P -17,502.

DIETARY_SUPPLEMENT

Placebo

Placebo is composed of maltodextrin which is easily digestible, being absorbed as rapidly as glucose. Maltodextrin listed by the U.S. Food and Drug Administration (FDA) as a safe food additive.

Trial Locations (1)

60123

Department of Pediatrics, via Corridoni 11, Ancona

All Listed Sponsors
collaborator

Noos S.r.l.

INDUSTRY

lead

Università Politecnica delle Marche

OTHER

NCT03857360 - Effectiveness of PENTABIOCEL in Clinical and Laboratory Recovery of Children With Celiac Disease | Biotech Hunter | Biotech Hunter